Evidence map›Paper›PMID 41211229›Full record

ArticleThe East African health research journal2025

High Prevalence of Sickle Cell Disease in Low-Endemic Areas: A Pilot Study in Chunya Tanzania.

Amani Twaha, Deocles Donatus, Khanafi Said, Moshi Moshi Shabani, Marygladness Ngeme, Maryjesca Mafie, Stamily Ally Ramadhani, Abdulrahman Hussein, Nazareth M Mbilinyi, Kasia Maksym

Abstract read
In one paragraph

Article in The East African health research journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amani TwahaRegency Medical Center, Ally Khan Road Dar es Salaam.
Deocles DonatusKamextra Pharmacy, Chunya Tanzania.
Khanafi SaidThe Research Department, One Health Society (OHS), Mpemba Street, Temeke, Dar es Salaam, Tanzania.
Moshi Moshi ShabaniThe Department of Biomedical Research and Clinical Trials, Ifakara Health Institute, Bagamoyo.
Marygladness NgemeThe Laboratory Services Department, Mbeya Zonal Referral Hospital.
Maryjesca MafieThe Laboratory Services Department, Mbeya Zonal Referral Hospital.
Stamily Ally RamadhaniUniversity of Dar Es Salaam, Mbeya College of Health and Allied Sciences.
Abdulrahman HusseinUniversity of Dar Es Salaam, Mbeya College of Health and Allied Sciences.
Nazareth M MbilinyiDepartment of Pediatrics, Mbeya Zonal Referral Hospital.
Kasia MaksymElizabeth Gareth Anderson Institute for Women's Health, University College London.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backround: Tanzania has the fifth highest prevalence of Sickle Cell Disease (SCD) worldwide. Annually, 11,000 children are born with SCD, but only 10% survive to their fifth birthday. Limited screening has led to underestimation of the burden in regions such as the southern highlands. The epidemiology of SCD, just like other diseases, is affected by climate change through increasing migration in search of arable land hence the shifts in the geographical prevalence of SCD from high prevalent areas to low prevalence areas. Early identification of SCD across all regions is therefore essential to improve survival, quality of life, mental health, reduce stigma, and alleviate the financial burden. Study Objective: The objective of the study was to assess the prevalence of SCD and SCT in Chunya district, Mbeya Region, Tanzania and to identify demographical factors associated with the risk of SCT among community members. Methods: A cross-sectional study on SCD was conducted in Chunya district, Mbeya Region, between 21 Results: The study revealed a notably high prevalence of SCD in southern highlands of Tanzania which highlighted the need for early screening and community-based awareness programs. The prevalence of SCD in the tested population was 1.91% and the prevalence of SCT was 8.41% of which the majority of the SCD patient were five years and below Conclusion: To reduce the burden of SCD, new strategies of screening should be developed to enable timely diagnosis and management of the disease.

Identifiers

PMID41211229
PMCPMC12591030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.